Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics [Yahoo! Finance]
Invitae Corporation (NVTA)
Last invitae corporation earnings: 2/19 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.invitae.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, designed to advance genetics-based drug discovery for rare diseases. The goal of the collaboration is to generate new insights focused on genetic modifiers and the discovery of novel therapeutic targets for rare diseases and other unmet medical needs. The agreement expands upon the longstanding partnership between the two companies to combine the strengths of BridgeBio's deep expertise in rare disease research and development of therapeutics, and Invitae's rare disease enriched dataset and analytical capabilities. Invitae has provided clinical testing for more than 4 million patients, generating an extensive dataset that is uniquely positioned to deepen insights on patients with genetic-driven disease. "Invitae is on a mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. By leveraging de-identified g
Show less
Read more
Impact Snapshot
Event Time:
NVTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVTA alerts
High impacting Invitae Corporation news events
Weekly update
A roundup of the hottest topics
NVTA
News
- Invitae gets court approval for five-month bankruptcy sale [Reuters]Reuters
- Invitae gets court approval for five-month bankruptcy sale [Yahoo! Finance]Yahoo! Finance
- Genetic Testing Firm Invitae, Backed by SoftBank and Cathie Wood, Files for Chapter 11 [Yahoo! Finance]Yahoo! Finance
- Invitae files for Chapter 11 bankruptcy to address huge debt load [Seeking Alpha]Seeking Alpha
- Genetic test maker Invitae files for bankruptcy protection in US [Reuters]Reuters
NVTA
Earnings
- 11/8/23 - Miss
NVTA
Sec Filings
- 2/14/24 - Form 8-K
- 2/13/24 - Form SC
- 2/13/24 - Form SC
- NVTA's page on the SEC website